LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
For over a decade, taking a pill like Truvada every day has been the standard of care for HIV prevention efforts. In clinical trials, this type of preventive drug, called pre-exposure prophylaxis ...
A new ad campaign from the AIDS Healthcare Foundation has kicked off another round of controversy about HIV pre-exposure prophylaxis, better known as PrEP. AHF argues that the scientific evidence does ...
A recent study published in JAMA Network Open evaluated the cost-effectiveness of monoclonal antibodies (mAbs) as pre-exposure prophylaxis (PrEP) for coronavirus disease 2019 (COVID-19). Study: Health ...
ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...
Colon cancer is the third leading cause of cancer death for both men and women in the U.S. and the second leading cancer death cause worldwide. But there’s good news: It’s also one of the most ...
A drug which reduces the risk of HIV is "extremely effective," a new study has affirmed as experts called for the drug to be used more widely. The study, which helped inform the widespread use of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results